ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

CIR Circassia Group Plc

34.00
0.00 (0.00%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Circassia Group Plc LSE:CIR London Ordinary Share GB00BJVD3B28 ORD 0.08P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 34.00 33.10 34.90 - 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Circassia Share Discussion Threads

Showing 926 to 948 of 3200 messages
Chat Pages: Latest  44  43  42  41  40  39  38  37  36  35  34  33  Older
DateSubjectAuthorDiscuss
04/3/2019
12:22
Shouldn't average down but have done a Woodford. My buys show as sells, just for info.Fingers crossed this isn't the basket case the share price reflects.
aspringo
22/2/2019
15:30
Is it starting to creep up we will see!
bc4
15/2/2019
13:30
Lets hope so seems to be drifting again
bc4
05/2/2019
12:18
This is starting to look a good risk/reward play now. It has been plagued by main market funds having to dump it recently. The shares have been picked up by Woodford on Friday.

By the 31st March , Azn and CIR have their joint development label for Duaklir, for approval by the US FDA . This is a significant date with a good chance of success.

Clearly oversold. A short term target of 60p seems achievable hopefully imo.

miti 1000
04/12/2018
14:55
Nobody noticed the huge spike today on results? Impressive 27% rise but there are warnings of multiple risks associated with Brexit.

This can't stay at these heady heights, surely?

yopf
23/10/2018
11:38
I didnt see any RNS. Whats the news?
nitinkhattar
23/10/2018
08:31
Looks like they misled investors
Class action on cards

jammytass
12/7/2018
08:53
For anyone wanting to find out more about Circassia there is a great article in the Telegraph today, lengthy interview with the CEO Steve Harris. Well worth a read to understand the potential here.
rathean
11/7/2018
15:14
Talking to myself as usual... back in (again) at 82.97.
rathean
05/7/2018
14:36
Back in today, looking for another bounce towards the top of its trading channel over the next week or two.
rathean
19/6/2018
13:35
That's me in at 83.97, reached floor of slow rising channel. No guarantees with Trump on Twitter but happy to get in at this price.
rathean
26/4/2018
09:39
I've got them on my watchlist, intriguing but high risk with huge cash burn and diminishing cash, although GSK investment mitigates that to some extent. Just not sure about this one, would welcome other opinions.
rathean
09/4/2018
14:12
Does anyone actually follow this stock? Would be interested to hear your thoughts?
savagedstock
09/2/2018
11:23
Just me, myself and I. So, apparently this is another Woodford hound high on the shorters list? Surely the recent big falls and curious auction buys at 75p suggest weighting now to the upside?
rathean
19/1/2018
15:34
Wow, no one in here for 9 months :/
rathean
18/4/2017
06:35
Dead again.
bulltradept
17/3/2017
10:11
From the DJN report -

"The deal is expected to improve earnings for Circassia after one year and to be broadly cash neutral for three years, then cash generative."

bandflex
17/3/2017
09:51
Silly me, I looked at that chart assumed AIM.
bandflex
17/3/2017
08:56
Forget AIM. That's irrelevant to the investment case
mirabeau
17/3/2017
08:54
Have to put it down to the vagaries of the AIM market.
bandflex
17/3/2017
08:51
Your guess is as good as mine.

it looks like a change in direction away from allergies.

either way the market loves today's news and I bet the agreement suits both parties

other than that, I am clueless...

mirabeau
17/3/2017
08:42
It will cost CIR up to $230m, plus royalties, and Circassia will make R&D contributions of up to US$62.5 million payable to AstraZeneca as deferred payments.
bandflex
17/3/2017
08:40
Interesting, but why is it going up. CIR are buying the rights from AStraZeneca to sell two AstraZeneca products not the other way around.
bandflex
Chat Pages: Latest  44  43  42  41  40  39  38  37  36  35  34  33  Older

Your Recent History

Delayed Upgrade Clock